GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 39 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2018. The put-call ratio across all filers is 34.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,799,694 | $1,224,000 | 0.06% |
| BRAVE ASSET MANAGEMENT INC | 11,470 | $8,000 | 0.00% |
| Western Wealth Management, LLC | 59,074 | $38,000 | 0.00% |
| PYA Waltman Capital, LLC | 1,000 | $1,000 | 0.00% |
| TSFG, LLC | 3,000 | $2,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 27,177 | $18,000 | 0.00% |
| Renaissance Technologies | 31,600 | $21,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 50,748 | $35,000 | 0.00% |
| CITIGROUP INC | 3,700 | $3,000 | 0.00% |
| UBS Group AG | 6,064 | $4,000 | 0.00% |